Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2023, which commenced on 3 July 2023. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2023.
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.
A complete list of the 5 changed ingredients is below.
Changed ingredients
Substance name | Change |
|---|---|
Refined Buglossoides arvensis seed oil | Addition |
Chicken sternum cartilage powder | Addition |
Change of name from Saccharomyces cervisiae polysaccharides to Saccharomyces cerevisiae polysaccharides | Change |
Violet leaf absolute | Change |
Poloxamine 1301 | Removal |
